MTOR and autoimmune polyendocrinopathy: Furthermore, mTOR inhibitors such as Sirolimus and RapaLink-1 demonstrate efficacy in APS, influencing cellular autophagy and protein synthesis, findings substantiated by experimental and case reports (149–154).